Key Takeaways
- Shares of AXT tumbled approximately 16% following a remarkable 548% year-to-date surge
- Chief Executive Morris Young liquidated stock holdings exceeding $22 million, triggering investor concern
- Board Director Jesse Chen disposed of shares worth more than $664,000 on June 4
- Trading price remains dramatically elevated compared to Wall Street’s consensus target of $43.80, versus recent levels between $89–$108
- The company reconvened its postponed annual shareholder meeting on June 4 after insufficient attendance
Shares of AXT Inc (AXTI) experienced a significant decline on June 5, surrendering approximately $16.95 to settle around $89.04. This represented a single-day contraction of roughly 16%.
The selloff follows a meteoric ascent. Despite the decline, AXT shares remain elevated 548% for the current year, positioning the stock substantially above levels analysts consider justified.
The catalyst appears to be executive stock disposals. Chief Executive Morris Young unloaded equity worth more than $22 million, a transaction that unnerved investors who had profited from the extended rally.
Board member Jesse Chen similarly divested 6,133 units on June 4 at an average execution price of $108.28, generating proceeds of approximately $664,081. This transaction diminished his stake by more than 6%, leaving him with 94,193 units valued at roughly $10.2 million.
Chen’s selling activity has been persistent. Throughout recent months, he has disposed of numerous units at execution prices spanning approximately $37 to $111 per share.
Price-to-Target Disconnect
The most significant challenge confronting the equity currently may be the disparity between market price and analyst expectations. Wall Street’s consensus valuation stands at merely $43.80, representing a small fraction of pre-Friday trading levels.
Northland Securities maintains an optimistic $125.00 target, while B. Riley sits at the opposite end with $21.00 and a “neutral” stance. Wedbush recently elevated its objective to $28.00 while maintaining an “outperform” rating — still considerably beneath recent market prices.
Among covering analysts, two maintain Buy recommendations, two advocate Hold positions, and one assigns a Sell rating. This divided outlook has provided limited comfort following substantial insider liquidations.
Financial Performance and Forward Outlook
AXT disclosed its latest quarterly performance on April 30. The semiconductor materials provider recorded a per-share loss of $0.01, surpassing consensus expectations calling for a $0.04 deficit. Top-line revenue reached $26.92 million, modestly exceeding the $26.22 million Wall Street projection.
For the upcoming quarter, management projected Q2 2026 earnings between $0.06 and $0.08 per share — indicating anticipated profitability in the near term.
Full-year analyst projections currently anticipate $0.20 in earnings per share.
The corporation also conducted its annual shareholder gathering on June 4 following an earlier postponement caused by inadequate attendance. This additional corporate event contributed to heightened news flow during an already volatile period.
Institutional stakeholders control approximately 49.52% of outstanding shares. Recent accumulation includes Ariose Capital Management establishing a fresh position valued at roughly $39 million during Q1, while Assenagon Asset Management expanded its holdings by 161.9% to surpass 1.5 million units.
AXTI’s 52-week trading range spans from $1.72 to $143.16, with Friday’s settlement at $89.04 positioned within those boundaries.
The equity’s 50-day moving average registers at $88.78, while the 200-day moving average stands at $46.83.


